183 related articles for article (PubMed ID: 3735498)
21. Survival after complete surgical resection of multiple metastases from renal cell carcinoma.
Alt AL; Boorjian SA; Lohse CM; Costello BA; Leibovich BC; Blute ML
Cancer; 2011 Jul; 117(13):2873-82. PubMed ID: 21692048
[TBL] [Abstract][Full Text] [Related]
22. [Clinical study on surgical treatment of renal cell carcinoma with pulmonary metastases].
Gotoh A; Mizuno Y; Gohji K; Ogawa T; Arakawa S; Matsumoto O; Kamidono S; Tobe S; Ishii N
Hinyokika Kiyo; 1992 Jul; 38(7):753-7. PubMed ID: 1524000
[TBL] [Abstract][Full Text] [Related]
23. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
24. Clinical study of brain metastasis of renal cell carcinoma.
Harada Y; Nonomura N; Kondo M; Nishimura K; Takahara S; Miki T; Okuyama A
Eur Urol; 1999 Sep; 36(3):230-5. PubMed ID: 10450008
[TBL] [Abstract][Full Text] [Related]
25. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy.
Casamassima A; Picciariello M; Quaranta M; Berardino R; Ranieri C; Paradiso A; Lorusso V; Guida M
J Urol; 2005 Jan; 173(1):52-5. PubMed ID: 15592024
[TBL] [Abstract][Full Text] [Related]
26. Prognosis in renal cell carcinoma: analysis of clinical course following nephrectomy.
Tobisu K; Kakizoe T; Takai K; Tanaka Y
Jpn J Clin Oncol; 1989 Jun; 19(2):142-8. PubMed ID: 2733167
[TBL] [Abstract][Full Text] [Related]
27. Renal cell carcinoma lung metastases surgery: pathologic findings and prognostic factors.
Assouad J; Petkova B; Berna P; Dujon A; Foucault C; Riquet M
Ann Thorac Surg; 2007 Oct; 84(4):1114-20. PubMed ID: 17888956
[TBL] [Abstract][Full Text] [Related]
28. Aggressive treatment of metastatic renal cancer.
Golimbu M; Al-Askari S; Tessler A; Morales P
J Urol; 1986 Oct; 136(4):805-7. PubMed ID: 3761436
[TBL] [Abstract][Full Text] [Related]
29. Analysis of pre-operative variables for identifying patients who might benefit from upfront cytoreductive nephrectomy for metastatic renal cell carcinoma in the targeted therapy era.
You D; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Ahn H; Kim CS
Jpn J Clin Oncol; 2015 Jan; 45(1):96-102. PubMed ID: 25341544
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers.
Mani S; Todd MB; Katz K; Poo WJ
J Urol; 1995 Jul; 154(1):35-40. PubMed ID: 7539867
[TBL] [Abstract][Full Text] [Related]
31. Treatment and survival of osseous renal cell carcinoma metastases.
Evenski A; Ramasunder S; Fox W; Mounasamy V; Temple HT
J Surg Oncol; 2012 Dec; 106(7):850-5. PubMed ID: 22623216
[TBL] [Abstract][Full Text] [Related]
32. Long-term patient survival after the surgical treatment of bone and soft-tissue metastases from renal cell carcinoma.
Higuchi T; Yamamoto N; Hayashi K; Takeuchi A; Abe K; Taniguchi Y; Kato S; Murakami H; Tsuchiya H
Bone Joint J; 2018 Sep; 100-B(9):1241-1248. PubMed ID: 30168767
[TBL] [Abstract][Full Text] [Related]
33. The natural history of metastatic renal cell carcinoma: a computer analysis.
Dekernion JB; Ramming KP; Smith RB
J Urol; 1978 Aug; 120(2):148-52. PubMed ID: 78992
[TBL] [Abstract][Full Text] [Related]
34. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.
Motzer RJ; Mazumdar M; Bacik J; Berg W; Amsterdam A; Ferrara J
J Clin Oncol; 1999 Aug; 17(8):2530-40. PubMed ID: 10561319
[TBL] [Abstract][Full Text] [Related]
35. The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy.
Choueiri TK; Xie W; Kollmannsberger C; North S; Knox JJ; Lampard JG; McDermott DF; Rini BI; Heng DY
J Urol; 2011 Jan; 185(1):60-6. PubMed ID: 21074201
[TBL] [Abstract][Full Text] [Related]
36. Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone.
Toyoda Y; Shinohara N; Harabayashi T; Abe T; Akino T; Sazawa A; Nonomura K
Eur Urol; 2007 Jul; 52(1):163-8. PubMed ID: 17098353
[TBL] [Abstract][Full Text] [Related]
37. Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.
Abel EJ; Spiess PE; Margulis V; Master VA; Mann M; Zargar-Shoshtari K; Borregales LD; Sexton WJ; Patil D; Matin SF; Wood CG; Karam JA
J Urol; 2017 Aug; 198(2):281-288. PubMed ID: 28268170
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors of adult metastatic renal carcinoma: a multivariate analysis.
de Forges A; Rey A; Klink M; Ghosn M; Kramar A; Droz JP
Semin Surg Oncol; 1988; 4(3):149-54. PubMed ID: 3187293
[TBL] [Abstract][Full Text] [Related]
39. Pattern of metastases in renal cell carcinoma: a single institution study.
Sivaramakrishna B; Gupta NP; Wadhwa P; Hemal AK; Dogra PN; Seth A; Aron M; Kumar R
Indian J Cancer; 2005; 42(4):173-7. PubMed ID: 16391434
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary metastasis from renal cell carcinoma 17 years after nephrectomy: report of two cases.
Tomita M; Shimizu T; Hara M; Ayabe T; Matsuzaki Y; Onitsuka T
Ann Thorac Cardiovasc Surg; 2009 Jun; 15(3):189-91. PubMed ID: 19597397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
